None listed
Conditions
Interventions
None listed
Sponsors
Semyung University Oriental Medicine Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Those who are between 20 and 80 years of age 2. Diabetic patients taking or administering an oral hypoglycemic agent or insulin OR Those with a fasting blood glucose level of 110 mg / dL or more OR those with a blood glucose level of 140 mg / dL or more for 2 hours after a meal 3. A person who voluntarily signs a clinical study agreement 4. Those who are willing to cooperate during the study period and who will comply with the restrictions
Exclusion criteria
Exclusion criteria: 1. Subjects with a history of drug hypersensitivity to medicines and food ingredients 2. Subjects who have severe cerebrovascular disease (cerebral infarction, cerebral hemorrhage, etc.), heart disease (angina pectoris, myocardial infarction, heart failure, arrhythmia requiring treatment), pulmonary disease (chronic obstructive pulmonary disease, etc.) within the last 6 months (However, patients who have a history of cerebrovascular disease or heart disease but are clinically stable can participate in the test by the judgment of the tester.) 3. Severe dysfunction of liver and kidney (ALT, AST = 2.5 times the upper limit of normal) (Creatinine> 2.0 mg / dl) 4. Diagnosis of malignancy within 3 years before screening 5. In the opinion of the person in charge of testing applied to the human body, the person who is judged to be unable to comply with the test 6. People with mental illness who are difficult to communicate 7. Subject of pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of blood glucose;Change of HbA1C;Change of HbA1C-IFCC1;Change of HbA1C-IFCC2 | — |
Secondary
| Measure | Time frame |
|---|---|
| body fat percentage;liver function test;lipid test;kidney function test | — |
Countries
Korea, Republic of
Contacts
Public ContactSeon-mi Shin
Semyung University
Outcome results
None listed